Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 22% ± 6% | |
epithelial cell | 4 studies | 24% ± 4% | |
astrocyte | 4 studies | 22% ± 3% | |
GABAergic neuron | 3 studies | 32% ± 10% | |
glutamatergic neuron | 3 studies | 41% ± 14% | |
abnormal cell | 3 studies | 24% ± 6% | |
transit amplifying cell | 3 studies | 23% ± 10% | |
oligodendrocyte | 3 studies | 23% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 28% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7805.66 | 1445 / 1445 | 100% | 91.07 | 183 / 183 |
ovary | 100% | 5767.77 | 180 / 180 | 100% | 90.50 | 430 / 430 |
prostate | 100% | 8798.98 | 245 / 245 | 100% | 93.83 | 502 / 502 |
uterus | 100% | 7150.79 | 170 / 170 | 100% | 97.85 | 459 / 459 |
brain | 100% | 7033.56 | 2640 / 2642 | 100% | 80.97 | 705 / 705 |
thymus | 100% | 7620.10 | 653 / 653 | 100% | 75.61 | 604 / 605 |
lung | 100% | 8001.22 | 578 / 578 | 100% | 86.09 | 1153 / 1155 |
breast | 100% | 5937.29 | 459 / 459 | 100% | 100.83 | 1116 / 1118 |
skin | 100% | 7662.36 | 1809 / 1809 | 100% | 117.78 | 471 / 472 |
stomach | 100% | 6105.27 | 359 / 359 | 100% | 80.91 | 285 / 286 |
kidney | 100% | 8925.13 | 89 / 89 | 99% | 70.29 | 896 / 901 |
intestine | 100% | 7911.94 | 966 / 966 | 99% | 79.98 | 524 / 527 |
bladder | 100% | 7362.62 | 21 / 21 | 99% | 87.31 | 501 / 504 |
pancreas | 99% | 3734.96 | 326 / 328 | 100% | 78.13 | 178 / 178 |
liver | 100% | 5888.27 | 226 / 226 | 99% | 81.71 | 402 / 406 |
adrenal gland | 100% | 9563.69 | 258 / 258 | 97% | 64.11 | 223 / 230 |
adipose | 100% | 5711.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 67.80 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 87.75 | 29 / 29 |
muscle | 100% | 8334.08 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8004.16 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 80.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.18 | 1 / 1 |
blood vessel | 100% | 6312.42 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 7643.18 | 855 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 7483.26 | 911 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006406 | Biological process | mRNA export from nucleus |
GO_0032210 | Biological process | regulation of telomere maintenance via telomerase |
GO_0000184 | Biological process | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0035303 | Biological process | regulation of dephosphorylation |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0005829 | Cellular component | cytosol |
GO_0005697 | Cellular component | telomerase holoenzyme complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070034 | Molecular function | telomerase RNA binding |
GO_0051721 | Molecular function | protein phosphatase 2A binding |
GO_0042162 | Molecular function | telomeric DNA binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | SMG5 |
Protein name | Nonsense-mediated mRNA decay factor SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog) (hSMG-5) |
Synonyms | KIAA1089 EST1B |
Description | FUNCTION: Plays a role in nonsense-mediated mRNA decay. Does not have RNase activity by itself. Promotes dephosphorylation of UPF1. Together with SMG7 is thought to provide a link to the mRNA degradation machinery involving exonucleolytic pathways, and to serve as an adapter for UPF1 to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation. Necessary for TERT activity. . |
Accessions | Q9UPR3 ENST00000361813.5 |